SRZN

Surrozen, Inc./DE

NasdaqCM · Healthcare

$19.84

-6.21% today

last filing 2026-07-22Pro sees filings in ~15 min

Price

hover · 4 moves explained

2 sells

Prices distorted

Reverse-split 1×. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what SRZN ever actually traded at. The drop is real, but those huge old numbers aren't.

Analyst consensus

Strong Buy

$42.50target+114.2%vs $19.84 today

$40.00 low today target$44.00 high

4 analysts · ~12-month consensus · as of Jul 26. Relayed analyst opinion, which tends to run optimistic — not our forecast or advice.

Earnings

Beat 1 of last 4

Earnings per share · actual vs forecast

Q2 '25+7.6%

−$1.14

exp −$1.23

Q3 '25

−$3.60

exp −$1.17

Q4 '25

−$9.62

exp −$1.24

Q1 '26

−$4.63

exp −$0.72

Type	Date	Insider	Title	Of stake	Shares	Price	Value
Sell	2026-07-24	TCG Crossover GP II, LLC	10% owner	—Indirect	162,500	$21.25	$3.45M
Sell	2026-07-24	TCG Crossover GP II, LLC	10% owner	—Indirect	162,500	$21.25	$3.45M
Grant	2026-06-16	Li Yang	Exec. Vice President, Research	—Direct	1,666	$8.11	$13.5K
Grant	2026-06-16	Williams Charles O	Chief Operating Officer	—Direct	1,666	$8.11	$13.5K

Sell

TCG Crossover GP II, LLC

10% owner · 2026-07-24

$3.45M

162,500 @ $21.25

Sell

TCG Crossover GP II, LLC

10% owner · 2026-07-24

$3.45M

162,500 @ $21.25

Grant

Li Yang

Exec. Vice President, Research · 2026-06-16

$13.5K

1,666 @ $8.11

Grant

Williams Charles O

Chief Operating Officer · 2026-06-16

$13.5K

1,666 @ $8.11